Employers that dropped GLP-1 coverage in 2026 (Mercer)
Metric EN-06 · Series EN: Employer Innovation
Employers that dropped GLP-1 coverage in 2026 (Mercer) was 6% in 2026, according to Mercer National Survey of Employer-Sponsored Health Plans 2025.
This figure is reported as Metric EN-06 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures employers that dropped glp-1 coverage in 2026 (mercer) among employers previously covering glp-1 medications. The unit of measurement is percent of employers. The geographic scope is United States.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| 6% | 2026 | Employers previously covering GLP-1 medications | United States |
Source
Mercer National Survey of Employer-Sponsored Health Plans 2025.
Methodological Notes
This figure is drawn from Mercer National Survey of Employer-Sponsored Health Plans 2025. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
- EN-01Large employers likely to continue GLP-1 coverage in 2027 (BGH survey)
- EN-02Large employers unlikely to continue GLP-1 coverage in 2027 (BGH survey)
- EN-03Large employers intending to maintain GLP-1 coverage (WTW survey)
- EN-04Large employers likely or very likely to discontinue GLP-1 coverage (WTW)
- EN-05Large employers somewhat likely to discontinue GLP-1 coverage (WTW)
Cite This Metric
Last reviewed: October 2026